UBI Pharma Inc. 6562.TWO Stock
UBI Pharma Inc. Price Chart
UBI Pharma Inc. 6562.TWO Financial and Trading Overview
| UBI Pharma Inc. stock price | 28 TWD |
| Previous Close | 36.25 TWD |
| Open | 35.9 TWD |
| Bid | 35.55 TWD x N/A |
| Ask | 35.85 TWD x N/A |
| Day's Range | 35.55 - 36.05 TWD |
| 52 Week Range | 30.6 - 58.8 TWD |
| Volume | 565.01K TWD |
| Avg. Volume | 215.41K TWD |
| Market Cap | 3.99B TWD |
| Beta (5Y Monthly) | 0.350684 |
| PE Ratio (TTM) | 87.43902 |
| EPS (TTM) | 0.36 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 25, 2016 |
| 1y Target Est | N/A |
6562.TWO Valuation Measures
| Enterprise Value | 4.15B TWD |
| Trailing P/E | 87.43902 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.293781 |
| Price/Book (mrq) | 3.5689397 |
| Enterprise Value/Revenue | 6.553 |
| Enterprise Value/EBITDA | 55.457 |
Trading Information
UBI Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 0.350684 |
| 52-Week Change | -33.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 58.8 TWD |
| 52 Week Low | 30.6 TWD |
| 50-Day Moving Average | 40.45 TWD |
| 200-Day Moving Average | 43.35 TWD |
6562.TWO Share Statistics
| Avg. Volume (3 month) | 215.41K TWD |
| Avg. Daily Volume (10-Days) | 319.06K TWD |
| Shares Outstanding | 111.27M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.44% |
| Operating Margin (ttm) | 5.88% |
| Gross Margin | 44.37% |
| EBITDA Margin | 11.81% |
Management Effectiveness
| Return on Assets (ttm) | 1.23% |
| Return on Equity (ttm) | 4.67% |
Income Statement
| Revenue (ttm) | 633.82M TWD |
| Revenue Per Share (ttm) | 5.77 TWD |
| Quarterly Revenue Growth (yoy) | -14.19% |
| Gross Profit (ttm) | 281.24M TWD |
| EBITDA | 74.9M TWD |
| Net Income Avi to Common (ttm) | 47.21M TWD |
| Diluted EPS (ttm) | 0.41 |
| Quarterly Earnings Growth (yoy) | -54.70% |
Balance Sheet
| Total Cash (mrq) | 395.34M TWD |
| Total Cash Per Share (mrq) | 3.55 TWD |
| Total Debt (mrq) | 514.37M TWD |
| Total Debt/Equity (mrq) | 46.01 TWD |
| Current Ratio (mrq) | 2.284 |
| Book Value Per Share (mrq) | 10.045 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 182.61M TWD |
| Levered Free Cash Flow (ttm) | 27.86M TWD |
Profile of UBI Pharma Inc.
| Country | Taiwan |
| State | N/A |
| City | Hsinchu City |
| Address | No.45, Guangfu North Road |
| ZIP | 303 |
| Phone | 886 3 597 9288 |
| Website | https://www.ubi-pharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan. The company offers protein drugs and formulations of molecule products; and develops biobetters and specialty injectables. Its product portfolio includes film coated, Virapine, and Efanzy tablets, as well as Terbutaline; and Levetir concentrate solution for infusion. The company was founded in 2014 and is based in Hsinchu City, Taiwan.
Q&A For UBI Pharma Inc. Stock
What is a current 6562.TWO stock price?
UBI Pharma Inc. 6562.TWO stock price today per share is 28 TWD.
How to purchase UBI Pharma Inc. stock?
You can buy 6562.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for UBI Pharma Inc.?
The stock symbol or ticker of UBI Pharma Inc. is 6562.TWO.
Which industry does the UBI Pharma Inc. company belong to?
The UBI Pharma Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does UBI Pharma Inc. have in circulation?
The max supply of UBI Pharma Inc. shares is 118.12M.
What is UBI Pharma Inc. Price to Earnings Ratio (PE Ratio)?
UBI Pharma Inc. PE Ratio is 77.77777000 now.
What was UBI Pharma Inc. earnings per share over the trailing 12 months (TTM)?
UBI Pharma Inc. EPS is 0.36 TWD over the trailing 12 months.
Which sector does the UBI Pharma Inc. company belong to?
The UBI Pharma Inc. sector is Healthcare.